Birchcreek Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Sell
1,164
-5
-0.4% -$5.07K 0.52% 37
2025
Q4
$1.26M Sell
1,169
-97
-8% -$92.7K 0.62% 29
2025
Q3
$966K Sell
1,266
-281
-18% -$209K 0.5% 39
2025
Q2
$1.21M Sell
1,547
-52
-3% -$40.4K 0.68% 31
2025
Q1
$1.32M Sell
1,599
-115
-7% -$95.7K 0.83% 21
2024
Q4
$1.32M Sell
1,714
-216
-11% -$179K 0.83% 23
2024
Q3
$1.71M Sell
1,930
-258
-12% -$232K 1.12% 19
2024
Q2
$1.98M Buy
2,188
+48
+2% +$38.4K 1.12% 17
2024
Q1
$1.66M Buy
2,140
+68
+3% +$48.4K 0.88% 28
2023
Q4
$1.21M Sell
2,072
-7
-0.3% -$4.09K 0.72% 38
2023
Q3
$1.12M Sell
2,079
-10
-0.5% -$5.15K 0.76% 36
2023
Q2
$980K Buy
2,089
+348
+20% +$146K 0.68% 42
2023
Q1
$598K Buy
1,741
+99
+6% +$33.4K 0.47% 54
2022
Q4
$601K Hold
1,642
0.53% 54
2022
Q3
$531K Hold
1,642
0.49% 57
2022
Q2
$532K Buy
1,642
+330
+25% +$99.1K 0.48% 53
2022
Q1
$376K Hold
1,312
0.33% 69
2021
Q4
$362K Hold
1,312
0.32% 72
2021
Q3
$303K Hold
1,312
0.28% 81
2021
Q2
$301K Hold
1,312
0.29% 79
2021
Q1
$245K Hold
1,312
0.26% 92
2020
Q4
$221K Buy
+1,312
New +$196K 0.22% 89

Other funds holding LLY

Birchcreek Wealth Management's LLY Position: Q1 2026 in Review

Birchcreek Wealth Management reduced its Eli Lilly (LLY) stake by 0.43% in Q1 2026, selling an estimated $5.07K and leaving 1,164 shares worth $1.07M. The position accounts for 0.52% of the portfolio, ranked #37.

Birchcreek Wealth Management first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.98M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Birchcreek Wealth Management held 1,164 shares of Eli Lilly worth $1.07M as of Q1 2026.
  • Birchcreek Wealth Management sold 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
  • Eli Lilly made up 0.52% of Birchcreek Wealth Management's portfolio in Q1 2026, its #37 holding.
  • Birchcreek Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Birchcreek Wealth Management's Eli Lilly position peaked at $1.98M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Birchcreek Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.